Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Zelavespib formic | 97.4% | 558.39 | 25 MG
SDP

Supplier:  Medchemexpress LLC 25MGHY11038D

Encompass_Preferred

Zelavespib formic (PU-H71 formic) is a potent Hsp90 inhibitor with an IC50 value of 51 nM for Hsp90 in MDA-MB-468 cells. It is intended for research use only.

  • Potent Hsp90 inhibitor
  • Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO
  • Available in various solid forms (5 mg, 10 mg, 25 mg, 50 mg, 100 mg)
  • Also available in solution form (10 mM * 1 mL in DMSO)
  • Cited in 12 publications
  • Related to various compound screening libraries and small molecules
  • Clinical trials listed for Metastatic Breast Cancer, Accelerated Phase MPN, Blast Phase MPN, Metastatic Solid Tumor, Lymphoma, Myeloproliferative Neoplasms (MPN), Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF)

Catalog No. 50-003-45536


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.